SCPH logo

SCPH

scPharmaceuticals Inc.

$5.50
-$0.01(-0.18%)
66
Overall
--
Value
90
Tech
42
Quality
Market Cap
$294.74M
Volume
4.38M
52W Range
$1.94 - $6.28
Target Price
$15.00
Order:

Income Statement

MetricTrendChart
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$39.0K$56.0K$51.0K$51.0K$47.0K$13.6M$36.3M
Total Revenue
$39.0K$56.0K$51.0K$51.0K$47.0K$13.6M$36.3M
COST OF GOODS SOLD
Cost of Revenue
----------$3.8M$11.4M
GROSS PROFIT
Gross Profit
$39.0K$56.0K$51.0K$51.0K$47.0K$9.8M$25.0M
OPERATING EXPENSES
Operating Expenses
$-29.7M$32.9M$29.9M$25.8M$36.2M$69.0M$101.1M
Research & Development
$15.9M$24.6M$18.1M$16.0M$15.5M$11.8M$12.1M
Research Expense
$15.9M$24.6M$18.1M$16.0M$15.5M$11.8M$12.1M
Selling, General & Administrative
$13.7M$8.3M$11.8M$9.8M$20.6M$53.4M$77.6M
Selling & Marketing Expenses
----------$79.0K$1.1M
General & Administrative Expenses
$13.7M$8.3M$11.8M$9.8M$20.6M$53.4M$77.6M
Promotion & Advertising
----------$79.0K$1.1M
Salaries & Wages
$-2.1M$-1.4M------$4.9M$5.4M
Depreciation & Amortization
$-38.0K$-37.0K$34.0K$34.0K$37.0K$24.0K$20.0K
Depreciation & Amortization
$-38.0K$-37.0K$34.0K$34.0K$37.0K$24.0K$20.0K
Other Operating Expenses
$-483.0K$-490.0K$-145.0K$-203.0K$-129.0K$-102.0K$-147.0K
OPERATING INCOME
Operating income
$-29.7M$-32.9M$-29.9M$-25.8M$-36.2M$-55.4M$-64.8M
EBITDA
$-27.7M$-30.9M$-29.2M$-24.9M$-33.1M$-46.1M$-77.4M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$1.4M$1.8M$2.6M$2.6M$3.3M$8.1M$7.6M
Intinc
$1.7M$1.7M$315.0K$49.0K$1.2M$5.1M$3.4M
Net Non-Operating Interest Income/Expense
$280.0K$-107.0K$-2.3M$-2.5M$-2.1M$-3.0M$-4.1M
Other Income/Expense
$56.0K$-16.0K$4.0K$-315.0K$1.4M$-3.6M$9.4M
Other Special Charges
$-56.0K$16.0K$-4.0K$315.0K$1.4M$3.6M$-9.4M
PRE-TAX INCOME
EBIT
$-28.0M$-31.2M$-29.6M$-25.5M$-33.5M$-46.7M$-77.6M
Pre-Tax Income
$-29.4M$-33.0M$-32.2M$-28.0M$-36.8M$-54.8M$-85.1M
NET INCOME
Net Income
$-29.4M$-33.0M$-32.2M$-28.0M$-36.8M$-54.8M$-85.1M
Net Income (Continuing Operations)
$-29.4M$-33.0M$-32.2M$-28.0M$-36.8M$-54.8M$-85.1M
Net Income (Discontinued Operations)
$-29.4M$-33.0M$-32.2M$-28.0M$-36.8M$-54.8M$-85.1M
Net Income (Common Stockholders)
$-29.4M$-33.0M$-32.2M$-28.0M$-36.8M$-54.8M$-85.1M
Normalized Income
------$-22.1M----$-77.5M
TOTALS
Total Expenses
$-29.7M$32.9M$29.9M$25.8M$36.2M$72.8M$112.5M
SHARE & EPS DATA
Average Shares Outstanding
$18.6M$18.6M$24.6M$27.4M$28.4M$38.5M$44.5M
Average Shares Outstanding (Diluted)
$18.5M$18.6M$24.6M--$28.4M$38.5M$44.5M
Shares Outstanding
$18.6M$21.0M$27.4M$27.4M$35.8M$36.1M$50.3M
Basic EPS
----$-1.31$-1.02$-1.3$-1.42$-1.91
Basic EPS (Continuing Operations)
----$-1.31$-1.02$-1.3$-1.42$-1.91
Diluted EPS
$-1.59$-1.77$-1.31$-1.02$-1.3$-1.42$-1.91
Diluted EPS (Continuing Operations)
--$-1.77----$-1.3$-1.42$-1.91
OTHER METRICS
Other Gand A
$13.7M$8.3M$11.8M$9.8M$20.6M$53.4M$77.6M
Rent And Landing Fees
$13.7M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2SCPH$5.50-0.2%4.38M
3
4
5
6

Get scPharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.